Keywords:
O’smir homilador qizlar, vulvovaginal kandidoz, Candida albicans, molekulyar diagnostika, qaytalanuvchi infeksiya.References
1. World Health Organization (WHO). Adolescent pregnancy. Geneva: WHO; 2023.
2. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Clinical Infectious Diseases. 2016;62(4):e1–e50.
3. Achkar, J. M., & Fries, B. C. (2010). Candida infections epidemiology and recurrence. Clinical Microbiology Reviews, n.p.
4. Donders GGG, Bellen G, Mendling W.Management of recurrent vulvovaginal candidosis as a chronic illness.Gynecol Obstet Invest. 2010;70(4): 306–321.
5. Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S.Vulvovaginal candidiasis: epidemiology, microbiology and risk factors.Critical Reviews in Microbiology. 2016;42(6):905–927.DOI: 10.3109/1040841X.2015.1091805
6. Yano J, Peters BM, Noverr MC, Fidel PL Jr.Novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: neutrophil anergy.Infection and Immunity. 2018;86(3):e00684-17. DOI: 10.1128/IAI.00684-17
7. Waikhom SD, Afeke I, Kwawu GS, et al.Prevalence of vulvovaginal candidiasis among pregnant women in Ghana.BMC Pregnancy and Childbirth. 2020;20:379.DOI: 10.1186/s12884-020-03046-8
8. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis. Lancet Infect Dis. 2018;18(11): e339–e347.DOI: 10.1016/S1473-3099(18)30103-8
9. Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369(9577): 1961–1971. DOI: 10.1016/ S0140-6736(07)60917-9
10. Arastehfar A, et al. Molecular identification of Candida species and antifungal resistance. J Fungi. 2020. DOI: 10.3390/jof6020065
